2019 annual financial data
BriaCell Therapeutics 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -6,252,448 USD and net income was -5,817,673 USD.
Operating cash flow was -5,119,544 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,252,448 USD
- Net income
- -5,817,673 USD
- Operating cash flow
- -5,119,544 USD